The IAEA is launching a year-long coordinated research project to develop computed tomography-based guidelines on prostate cancer contouring — a critical step in the cancer treatment process that ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early ...

By Dr Wendy Winnall - PCFA Research TeamA recent prostate cancer study from Canada has received a lot of publicity. This study measured the risk of ...

Assessments used to calculate cardiovascular disease risk in the general population may not have the same predictive power ...

Lower urinary tract symptoms are not associated with an increased risk for high-grade prostate cancer, rendering biopsies and antigen testing unnecessary, a case-control study reports.

Daily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment, reducing the risk of ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at ...

In a heartfelt revelation, Dr. Timothy Johnson, the esteemed former medical editor for WCVB and ABC News, disclosed his ongoing battle with prostate cancer during an appearance on ...

By Oluseye OjoIn Nigeria, prostate cancer is a silent killer of men, claiming approximately 31 lives daily.In 2022, records showed that the country recorded 18,019 new cases, resulting in 11,443 ...

A published case series reports unexpected cancer remissions linked with fenbendazole use, prompting renewed discussion on ...

Here are the top 5 stories from 2025 about the advancements in prostate, kidney, and bladder cancers.

Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population.